Unknown

Dataset Information

0

MiR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.


ABSTRACT: The BCL6 (B-Cell Lymphoma 6) gene is a proto-oncogene that is often expressed in diffuse large B-cell lymphomas (DLBCLs). BCL6 loss of function can kill DLBCL cells, demonstrating that BCL6 is necessary for the survival of DLBCL cells and could be a therapeutic target. In this study, we found that BCL6 protein levels were consistently upregulated in DLBCL tissues, whereas its mRNA levels varied randomly in tissues, suggesting that a post-transcriptional mechanism was involved in BCL6 regulation. We used bioinformatics analysis to search for miRNAs, which potentially target BCL6, and identified specific targeting sites for miR-10a in the 3'-untranslated region (3'-UTR) of BCL6. We further identified an inverse correlation between miR-10a levels and BCL6 protein levels, but not mRNA levels, in DLBCL tumor tissue samples. By overexpressing or knocking down miR-10a in DLBCL cells, we experimentally validated that miR-10a directly recognizes the 3'-UTR of the BCL6 transcript and regulated BCL6 expression. Furthermore, we demonstrated that negatively regulating BCL6 by miR-10a suppressed the proliferation and promoted apoptosis of DLBCL cells.

SUBMITTER: Fan Q 

PROVIDER: S-EPMC5205661 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.

Fan Qian Q   Meng Xiangrui X   Liang Hongwei H   Zhang Huilai H   Liu Xianming X   Li Lanfang L   Li Wei W   Sun Wu W   Zhang Haiyang H   Zen Ke K   Zhang Chen-Yu CY   Zhou Zhen Z   Chen Xi X   Ba Yi Y  

Protein & cell 20161104 12


The BCL6 (B-Cell Lymphoma 6) gene is a proto-oncogene that is often expressed in diffuse large B-cell lymphomas (DLBCLs). BCL6 loss of function can kill DLBCL cells, demonstrating that BCL6 is necessary for the survival of DLBCL cells and could be a therapeutic target. In this study, we found that BCL6 protein levels were consistently upregulated in DLBCL tissues, whereas its mRNA levels varied randomly in tissues, suggesting that a post-transcriptional mechanism was involved in BCL6 regulation.  ...[more]

Similar Datasets

| S-EPMC8017314 | biostudies-literature
| S-EPMC7645330 | biostudies-literature
| S-EPMC6815839 | biostudies-literature
| S-EPMC5004937 | biostudies-literature
| S-EPMC7904539 | biostudies-literature
| S-EPMC5362454 | biostudies-literature
| S-EPMC2708681 | biostudies-literature
| S-EPMC9378967 | biostudies-literature
| S-EPMC8562389 | biostudies-literature
| S-EPMC8125500 | biostudies-literature